MDRX — Veradigm Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid Cap

Annual cashflow statement for Veradigm, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-133	134	-20	49.2	-292
Depreciation
Deferred Taxes
Non-Cash Items	-10.8	-360	18.1	44.7	189
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-152	-23.5	57.4	-18	-30.8
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-107	-75.4	116	99.5	-20
Capital Expenditures	-105	-78.6	-32.3	-29.4	-30.2
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items	1,720	66.4	617	-59	-95.5
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	1,615	-12.2	585	-88.3	-126
Financing Cash Flow Items	-10.4	-16.4	-32.1	-12.5	-6.65
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1,110	-259	-445	-12.5	-6.65
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	400	-347	256	-1.3	-152